← All stocks

Quoin Pharmaceuticals, Ltd.

QNRX Net buying
CIK 0001671502 #5246 in the set updated 17 Sep 2026
Bought (120 mo)
$1.09M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$217.40
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$217.40
1 of 1 sales
Net
+$1.09M
+$1.09M against sales at will

By person

6 insiders · 23 transactions
4.1×

Dr. Michael Myers holds only 4.1 times base salary in stock. $3.13M of shares against $745.28K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. Michael Myers last reported holding, valued at $4.88, the price ADSs was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Myers Michael
Chief Executive Officer
$378.91K (6)
+$378.91K
640,521
$3.13M
+2,310%
Carter Denise P.
Chief Operating Officer
$378.73K (6)
+$378.73K
640,357
$3.12M
+2,310%
LANGER DENNIS
Director
$128.64K (1)
$217.40 (1)
+$128.42K
56,296
$274.72K
+715.1%
Dunn Gordon
Chief Financial Officer
$78.20K (6)
+$78.20K
151,077
$737.26K
Culverwell Anthony James
Director
$74.99K (2)
+$74.99K
140,681
$686.52K
+4,320%
Lawlor Sally Bridget
Chief Financial Officer
$49.99K (1)
+$49.99K
10,684
$52.14K
+2,328%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 65,886
History held since 30 Oct 2023